Home LiteratureArticle Details
PMID: 15314695 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice.

The Journal of clinical investigation ·Vol. 114 ·No. 4 ·2004-08-00 ·Pages 582-8

Hata H, Sakaguchi N, Yoshitomi H, Iwakura Y, Sekikawa K, Azuma Y, Kanai C, Moriizumi E, Nomura T, Nakamura T, Sakaguchi S

Abstract

Cytokines play key roles in spontaneous CD4(+) T cell-mediated chronic autoimmune arthritis in SKG mice, a new model of rheumatoid arthritis. Genetic deficiency in IL-6 completely suppressed the development of arthritis in SKG mice, irrespective of the persistence of circulating rheumatoid factor. Either IL-1 or TNF-alpha deficiency retarded the onset of arthritis and substantially reduced its incidence and severity. IL-10 deficiency, on the other hand, exacerbated disease, whereas IL-4 or IFN-gamma deficiency did not alter the disease course. Synovial fluid of arthritic SKG mice contained high amounts of IL-6, TNF-alpha, and IL-1, in accord with active transcription of these cytokine genes in the afflicted joints. Notably, immunohistochemistry revealed that distinct subsets of synovial cells produced different cytokines in the inflamed synovium: the superficial synovial lining cells mainly produced IL-1 and TNF-alpha, whereas scattered subsynovial cells produced IL-6. Thus, IL-6, IL-1, TNF-alpha, and IL-10 play distinct roles in the development of SKG arthritis; arthritogenic CD4(+) T cells are not required to skew to either Th1 or Th2; and the appearance of rheumatoid factor is independent of joint inflammation. The results also indicate that targeting not only each cytokine but also each cell population secreting distinct cytokines could be an effective treatment of rheumatoid arthritis.

MeSH Terms
Animals Arthritis, Experimental/genetics,immunology,metabolism,pathology Autoantibodies/immunology,metabolism CD4-Positive T-Lymphocytes/immunology,metabolism Cell Division Disease Models, Animal Enzyme-Linked Immunosorbent Assay Female Fibroblasts/metabolism,ultrastructure Heterozygote Homozygote Immunohistochemistry Interleukin-1/deficiency,genetics,immunology,metabolism Interleukin-10/immunology,metabolism Interleukin-6/deficiency,genetics,immunology,metabolism Macrophages/ultrastructure Mice Mice, Inbred BALB C Mice, Inbred Strains Mice, Knockout Proteins/analysis RNA, Messenger/metabolism Synovial Fluid/cytology,metabolism Synovitis/immunology,metabolism T-Lymphocytes/immunology,metabolism Tumor Necrosis Factor-alpha/deficiency,genetics,immunology,metabolism
Chemicals
Autoantibodies Interleukin-1 Interleukin-6 Proteins RNA, Messenger Tumor Necrosis Factor-alpha Interleukin-10
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Hata Hiroshi
Department of Experimental Pathology, Institute for Frontier Medical Sciences, Kyoto University, 53 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.
Sakaguchi Noriko
Yoshitomi Hiroyuki
Iwakura Yoichiroh
Sekikawa Kenji
Azuma Yoshiaki
Kanai Chieko
Moriizumi Eiko
Nomura Takashi
Nakamura Takashi
Sakaguchi Shimon
References (48)
48 references, click to expand
  1. Lipopolysaccharide-induced HIV-1 expression in transgenic mice is mediated by tumor necrosis factor-alpha and interleukin-1, but not by interferon-gamma nor interleukin-6.
    AIDS. 2000 Jul 7;14(10):1299-307 PMID: 10930143
  2. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation.
    J Exp Med. 1999 Oct 4;190(7):995-1004 PMID: 10510089
  3. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma.
    Nature. 2000 Nov 30;408(6812):600-5 PMID: 11117749
  4. Cytokines and direct cell contact in synovitis: relevance to therapeutic intervention.
    Arthritis Res. 1999;1(1):17-20 PMID: 11094408
  5. The TNF and TNF receptor superfamilies: integrating mammalian biology.
    Cell. 2001 Feb 23;104(4):487-501 PMID: 11239407
  6. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
    Annu Rev Immunol. 2001;19:163-96 PMID: 11244034
  7. Physiology of cytokine pathways in rheumatoid arthritis.
    Arthritis Rheum. 2001 Feb;45(1):101-6 PMID: 11308054
  8. Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis.
    J Exp Med. 2002 Jul 1;196(1):77-85 PMID: 12093872
  9. The paradigm of IL-6: from basic science to medicine.
    Arthritis Res. 2002;4 Suppl 3:S233-42 PMID: 12110143
  10. Tumor necrosis factor-alpha regulation of CD4+CD25+ T cell levels in NOD mice.
    Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12287-92 PMID: 12221281
  11. Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial.
    Arthritis Rheum. 2002 Dec;46(12):3143-50 PMID: 12483717
  12. Control of regulatory T cell development by the transcription factor Foxp3.
    Science. 2003 Feb 14;299(5609):1057-61 PMID: 12522256
  13. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells.
    Science. 2003 Feb 14;299(5609):1033-6 PMID: 12532024
  14. Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy.
    Arthritis Rheum. 2003 Mar;48(3):594-601 PMID: 12632409
  15. CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis.
    Arthritis Rheum. 2003 May;48(5):1452-60 PMID: 12746920
  16. Systemic overexpression of IL-10 induces CD4+CD25+ cell populations in vivo and ameliorates type 1 diabetes in nonobese diabetic mice in a dose-dependent fashion.
    J Immunol. 2003 Sep 1;171(5):2270-8 PMID: 12928371
  17. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice.
    Nature. 2003 Nov 27;426(6965):454-60 PMID: 14647385
  18. Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.
    J Exp Med. 1985 Dec 1;162(6):2163-8 PMID: 2999289
  19. Augmented interleukin-1 production and HLA-DR expression in the synovium of rheumatoid arthritis patients. Possible involvement in joint destruction.
    Arthritis Rheum. 1988 Apr;31(4):480-6 PMID: 3258750
  20. Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis.
    J Clin Invest. 1989 Feb;83(2):585-92 PMID: 2464001
  21. Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): correlation with rheumatoid arthritis.
    Ann Rheum Dis. 1989 Aug;48(8):645-53 PMID: 2675782
  22. Thymus and autoimmunity: capacity of the normal thymus to produce pathogenic self-reactive T cells and conditions required for their induction of autoimmune disease.
    J Exp Med. 1990 Aug 1;172(2):537-45 PMID: 2373992
  23. Efficient and selective presentation of antigen-antibody complexes by rheumatoid factor B cells.
    J Exp Med. 1991 Feb 1;173(2):487-9 PMID: 1703209
  24. Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis.
    Arthritis Rheum. 1991 Sep;34(9):1125-32 PMID: 1930331
  25. The VLA-4/VCAM-1 pathway is involved in lymphocyte adhesion to endothelium in rheumatoid synovium.
    J Immunol. 1991 Dec 15;147(12):4207-10 PMID: 1721640
  26. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes.
    Science. 1993 Mar 19;259(5102):1739-42 PMID: 8456300
  27. Interleukin-10-deficient mice develop chronic enterocolitis.
    Cell. 1993 Oct 22;75(2):263-74 PMID: 8402911
  28. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
    Arthritis Rheum. 1993 Dec;36(12):1681-90 PMID: 8250987
  29. Cytokine signal transduction.
    Cell. 1994 Jan 28;76(2):253-62 PMID: 8293462
  30. Immunoregulatory role of interleukin 10 in rheumatoid arthritis.
    J Exp Med. 1994 May 1;179(5):1517-27 PMID: 8163935
  31. The type I interleukin-1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF-transgenic mice.
    Eur J Immunol. 1995 Jun;25(6):1794-7 PMID: 7615010
  32. Apoptosis in rheumatoid arthritis synovium.
    J Clin Invest. 1995 Sep;96(3):1631-8 PMID: 7657832
  33. Detection of cytokine producing cells in the synovial membrane from patients with rheumatoid arthritis.
    Ann Rheum Dis. 1995 Aug;54(8):654-61 PMID: 7677442
  34. Interleukin-10 inhibition of the progression of established collagen-induced arthritis.
    Arthritis Rheum. 1996 Mar;39(3):495-503 PMID: 8607899
  35. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra.
    Arthritis Rheum. 1996 May;39(5):797-809 PMID: 8639177
  36. Role of cytokines in rheumatoid arthritis.
    Annu Rev Immunol. 1996;14:397-440 PMID: 8717520
  37. Efficient targeting of the IL-4 gene in a BALB/c embryonic stem cell line.
    Transgenic Res. 1996 Nov;5(6):487-91 PMID: 8840532
  38. Interleukin-10 suppresses the development of collagen type II-induced arthritis and ameliorates sustained arthritis in rats.
    Scand J Immunol. 1996 Dec;44(6):607-14 PMID: 8972743
  39. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction.
    Arthritis Rheum. 1997 Feb;40(2):249-60 PMID: 9041936
  40. Dynamics of proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis (CIA).
    Clin Exp Immunol. 1997 Mar;107(3):507-12 PMID: 9067525
  41. Rheumatoid factor autoantibodies in health and disease.
    Ann N Y Acad Sci. 1997 Apr 5;815:296-311 PMID: 9186666
  42. Interleukin-6 reduces cartilage destruction during experimental arthritis. A study in interleukin-6-deficient mice.
    Am J Pathol. 1997 Jul;151(1):177-91 PMID: 9212744
  43. Interleukin 6 is required for the development of collagen-induced arthritis.
    J Exp Med. 1998 Feb 16;187(4):461-8 PMID: 9463396
  44. Borrelia burgdorferi-infected, interleukin-6-deficient mice have decreased Th2 responses and increased lyme arthritis.
    J Infect Dis. 1998 Nov;178(5):1512-5 PMID: 9780277
  45. Signal transduction and transcription factors in rheumatic disease.
    Arthritis Rheum. 1999 Apr;42(4):609-21 PMID: 10211874
  46. Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis.
    J Immunol. 1999 Aug 1;163(3):1521-8 PMID: 10415055
  47. Delayed onset and reduced severity of collagen-induced arthritis in interleukin-6-deficient mice.
    Arthritis Rheum. 1999 Aug;42(8):1635-43 PMID: 10446862
  48. Susceptibility to collagen-induced arthritis: cytokine-mediated regulation.
    Clin Immunol. 2001 Jan;98(1):109-18 PMID: 11141333
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
2004-08-00
Pages
582-8
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC503774
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com